Dr. Jung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3810 Springhurst Blvd
Ste 200
Louisville, KY 40241Phone+1 502-583-1749Fax+1 502-329-8184
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 2008 - 2011
- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2006 - 2007
- Washington University in St. Louis School of MedicineClass of 2005
- Washington UniversityPhD, 1998 - 2003
- University of California, DavisNo Degree, 1997 - 1998
- University of California, DavisBS, Biochemistry, 1991 - 1995
Certifications & Licensure
- CA State Medical License 2012 - Present
- KY State Medical License 2016 - 2025
- UT State Medical License 2011 - 2014
- MO State Medical License 2010 - 2012
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Resident Presentation Award Missouri Dermatologic Society, 2010
- Travel Award Association for Research in Otolaryngology, 25th Annual Meeting, 2002
- Invited Speaker 3rd International Symposium, Cholesteatoma Research (Bochum, Germany), 2001
- Join now to see all
Clinical Trials
- Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer Start of enrollment: 2020 Sep 14
Publications & Presentations
PubMed
- 91 citationsHuman breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression.Colt Egelston, Christian Avalos, Travis Y. Tu, Diana L. Simons, Grecia Jimenez
Nature Communications. 2018-10-16 - 19 citationsCutaneous Metastasis.John D Strickley, Alfred Bennett Jenson, Jae Yeon Jung
Hematology/oncology Clinics of North America. 2019-02-01 - 75 citationsTumor Immunotherapy by Epicutaneous Immunization Requires Langerhans CellsPatrizia Stoitzner, Laura K. Green, Jae Y. Jung, Kylie M. Price, Christoph H. Tripp
Journal of Immunology. 2008-02-01
Journal Articles
- Survivin promotion of melanoma metastasis requires upregulation of integrin alpha 5 integrinMackenzie J, Liu T, Jung J, Jones B, Welm A, Grossman D, Carcinogenesis, 9/1/2013
- Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysisRirie MR1, Blaylock RC, Morris SE, Jung J, J Am Acad Dermatol, 8/1/2013
- Familial Melanoma-Associated Mutations in p16 Uncouple its Tumor-Suppressor FunctionsJenkins NC, Jung J, Liu T, Wilde M, Holmen SL, Grossman D, J Invest Dermatol, 4/1/2013
- Join now to see all
Abstracts/Posters
- Pseudomonas aeruginosa adhesion and cytotoxicity in keratinocytes and A549 pulmonary epithelial cells.Jung J, Wang E, Sinwell T, Cornelius L, Chole R, Society for Investigative Dermatology 69th Annual Meeting, Montreal, Canada, 1/1/2009
- Pseudomonas aeruginosa adhesion and invasion of human keratinocytes.Jung J, Nason R, Wang E, Pashia M, Cornelius L, Chole R, Society for Investigative Dermatology 66th Annual Meeting, St. Louis, MO, 1/1/2005
- Otopathogenic Pseudomonas aeruginosa exhibits biofilm-forming characteristics: initial observations.Wang E, Pashia M, Jung J, Chole R, 8th International Symposium on Recent Advances in Otitis Media, Ft. Lauderdale, FL, 1/1/2003
Lectures
- Side Effects May Include: Illustrative Cases of Dermatologic Adverse EventsAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
- Dermatologic Reactions and Grading.Memorial Sloan Kettering, New York, NY - 1/1/2013
- Dermatologic Complications of BMT and Immunosuppression in Cancer Patients.Duarte, CA - 1/1/2013
- Join now to see all
Press Mentions
- Tips to Stay Sun Smart This SummerJune 25th, 2017
- Vitamin B3 Could Help Reduce Skin Cancer RiskMay 14th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: